Further Information
Proto-oncogene tyrosine-protein kinase receptor Ret, Cadherin family member 12, Proto-oncogene c-Ret, Soluble RET kinase fragment, Extracellular cell-membrane anchored RET cadherin 120 kDa fragment, RET, CDHF12, CDHR16, PTC, RET51
For WB starting dilution is: 1:1000
This gene, a member of the cadherin superfamily, encodes one of the receptor tyrosine kinases, which are cell-surface molecules that transduce signals for cell growth and differentiation. This gene plays a crucial role in neural crest development, and it can undergo oncogenic activation in vivo and in vitro by cytogenetic rearrangement. Mutations in this gene are associated with the disorders multiple endocrine neoplasia, type IIA, multiple endocrine neoplasia, type IIB, Hirschsprung disease, and medullary thyroid carcinoma. Two transcript variants encoding different isoforms have been found for this gene. Additional transcript variants have been described but their biological validity has not been confirmed.
- Siqueira, D.R., et al. Endocr. Relat. Cancer 17(4):953-963(2010) Gockel, H.R., et al. Hum. Genet. 128(4):353-364(2010) Kim, H.K., et al. Anticancer Res. 30(9):3621-3627(2010) Pacini, F., et al. Clin Oncol (R Coll Radiol) 22(6):475-485(2010) Jugessur, A., et al. PLoS ONE(7), E11493 (2010) :
Supplied in PBS with 0.09% (W/V) sodium azide.
batch dependent
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
This RET antibody is generated from rabbits immunized with His fusion protein of human RET.
5979
Proto-oncogene tyrosine-protein kinase receptor Ret
RET
Homo sapiens
Liquid
PREDICTED MOLECULAR WEIGHT:
124 kDa
P07949
547807
This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis
Cancer,Signal Transduction
P07949
Optimal dilutions for each application to be determined by the researcher.